The Global Enzyme-Linked Immunosorbent Assay (ELISA) Market report provides a holistic evaluation of the market for the forecast period. The report comprises various segments as well as an analysis of the trends and factors that are playing a substantial role in the market. These factors; the market dynamics involve the drivers, restraints, opportunities, and challenges through which the impact of these factors in the market is outlined. The drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market. The Global Enzyme-Linked Immunosorbent Assay (ELISA) Market study provides an outlook on the development of the market in terms of revenue throughout the prognosis period.
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities, and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market. ELISA is significantly used as a screening tool for HIV AIDS, therefore surging its demand in the market. The growing applications of ELISA in oncology have boosted the market. ELISA is prominently used by researchers and students in biotechnology academic instituted and research laboratories, which has helped to propel the market. However, the presence of several other immunoassay methods might hamper the growth of ELISA.
Geographically, the global enzyme-linked immunosorbent assay market can be categorized into North America, Europe, Asia-Pacific and rest of the world regions. North America,particularly the United States currently leads this marketand is followed by Europe due to widespread existence and early adoption of highly developed technologies and supportive economy. Asia-Pacific is a promising market for ELISA kits and is expected to undergo rapid market growth. Especially countries like China and India are promising regions, reason being rapidly growing medical tourism industry in India and China will increase the use of ELISA test as a diagnostic tool.
Some of the market players leading the enzyme-linked immunosorbent assay (ELISA) market include Ortho-Clinical Diagnostics, Inc., Thermo Fisher Scientific. Inc., Life Technologies Corporation and ZEUS Scientific, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Enzyme-Linked Immunosorbent Assay Market, By Type
• Sandwich ELISA
• Indirect ELISA
• Competitive ELISA
Enzyme-Linked Immunosorbent Assay Market, By Application
• HIV AIDS
• Inflammation Disorders
• Protein Quantification
Enzyme-Linked Immunosorbent Assay Market, By Geographic Scope
• North America
o Rest of Europe
• Asia Pacific
o Rest of Asia Pacific
• Rest of the World